查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1314890

電子藥局市場：按產品類型（感冒/流感、牙科、皮膚護理）、按藥品類型（非處方藥、處方藥）、按類型、按商業模式 - 2023-2030 年全球預測

ePharmacy Market by Product (Cold & Flu, Dental, Skin Care), Drug Type (Over the Counter (OTC) Drugs, Prescription Drugs), Type, Business model - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Global Forecast 2023-2030
出版日期: | 出版商: 360iResearch | 英文 188 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

全球電子藥局市場預計將大幅成長，到 2023 年將達到 536.2 億美元，年複合成長率為 17.21%，到 2030 年將達到驚人的 1,638.4 億美元。

FPNV定位矩陣

FPNV定位矩陣對於評估全球電子藥局市場至關重要。透過檢查業務策略和產品滿意度的關鍵指標，我們對供應商進行全面評估，使您能夠根據您的特定需求做出明智的資訊。這種進階分析將供應商分為四個像限，並取得了不同程度的成功：前沿 (F)、探路者 (P)、利基 (N) 和重要 (V)。

市佔率分析

市場佔有率分析可以深入了解供應商在特定市場領域的當前地位。比較供應商對總收入、基本客群和其他關鍵指標的貢獻，可以幫助公司更好地了解他們在爭奪市場佔有率時的表現以及面臨的情況。該分析還揭示了特定行業的競爭程度、累積和合併的優勢以及研究基準年的合併特徵。

本報告提供了以下幾點見解：

1. 市場滲透率：提供有關主要企業所服務的市場的全面資訊。

2. 市場開發：提供有關利潤豐厚的新興市場的詳細資訊，並分析其在成熟市場的滲透率。

3. 市場多元化：提供有關新產品發布、未開發領域、最新發展和投資的詳細資訊。

4.市場趨勢：全面了解COVID-19、俄羅斯-烏克蘭衝突和高通膨的累積影響。

5.競爭評估與資訊：對主要企業的市場佔有率、策略、產品、認證、法規狀況、專利狀況、製造能力等進行綜合評估。

6. 產品開發與創新：提供對未來技術、研發活動和突破性產品開發的見解。

本報告回答了以下問題：

1.全球電子藥局市場規模及預測是多少？

2. 在預測期內，COVID-19 對全球電子藥局市場的阻礙因素與影響有哪些？

3.在預測期內，全球電子藥局市場需要投資哪些產品/細分市場/用途/領域？

4.ePharmacy在全球市場的競爭策略是什麼？

5.全球電子藥局市場的技術趨勢和法律規範是什麼？

6.全球電子藥局市場主要廠商的市佔率是多少？

7.您認為ePharmacy進入全球市場適合採取型態與策略措施？

目錄

第1章 前言

第2章 調查方法

第3章 執行摘要

第4章 市場概況

第5章 市場洞察

  • 市場動態
    • 促進因素
      • 醫療保健領域快速採用數位技術和電子商務，以提高可及性和彈性
      • 電話諮詢在世界各地不斷發展，電子藥房功能也擴大被引入
      • 世界各地患有慢性和急性疾病的老年人數量正在增加。
    • 抑制因素
      • 電子藥局的發展需要技術專長和適當的基礎設施
    • 機會
      • 人工智慧和區塊鏈技術在電子藥房的引入
      • 在電子藥局引入虛擬協助
    • 任務
      • 對電子藥局中藥品標籤不當的擔憂
      • 駭客和網路釣魚活動的出現導致病患資料隱私和安全問題
  • 市場趨勢
  • COVID-19 的累積影響
  • 俄羅斯-烏克蘭衝突的累積影響
  • 高通膨的累積效應
  • 波特五力分析
  • 價值鍊和關鍵路徑分析
  • 法律規範
  • 客戶客製化

第6章 電子藥局市場：副產品

  • 介紹
  • 感冒/流感
  • 牙科
  • 皮膚護理
  • 維他命
  • 減重

第7章 電子藥局市場：依藥品類型

  • 介紹
  • 商店(OTC) 藥物
  • 處方藥

第8章 電子藥局市場：按類型

  • 介紹
  • 整合的
  • 獨立的

第9章 電子藥局市場：依商業模式

  • 介紹
  • 直銷
  • 市場
  • 藥局

第10章 美洲電子藥局市場

  • 介紹
  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第11章亞太電子藥局市場

  • 介紹
  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第12章歐洲、中東和非洲電子藥局市場

  • 介紹
  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第13章競爭形勢

  • FPNV定位矩陣
  • 市佔率分析：主要企業
  • 競爭情境分析：主要企業
    • 併購
    • 新產品發布和功能增強
    • 投資、資金籌措
    • 獎項/獎勵/擴展

第14章上市公司名單

第15章附錄

  • 討論指南
  • 關於許可證和定價
Product Code: MRR-8C74ADFBFB1C

The Global ePharmacy Market is forecasted to grow significantly, with a projected USD 53.62 billion in 2023 at a CAGR of 17.21% and expected to reach a staggering USD 163.84 billion by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global ePharmacy Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global ePharmacy Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Product, market is studied across Cold & Flu, Dental, Skin Care, Vitamins, and Weight Loss. The Cold & Flu commanded largest market share of 17.57% in 2022, followed by Weight Loss.

Based on Drug Type, market is studied across Over the Counter (OTC) Drugs and Prescription Drugs. The Prescription Drugs commanded largest market share of 74.01% in 2022, followed by Over the Counter (OTC) Drugs.

Based on Type, market is studied across Integrated and Standalone. The Integrated commanded largest market share of 65.22% in 2022, followed by Standalone.

Based on Business model, market is studied across Direct, Marketplace, and Pharmacy. The Pharmacy commanded largest market share of 56.68% in 2022, followed by Direct.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 40.65% in 2022, followed by Europe, Middle East & Africa.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global ePharmacy Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global ePharmacy Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global ePharmacy Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global ePharmacy Market?

4. What is the competitive strategic window for opportunities in the Global ePharmacy Market?

5. What are the technology trends and regulatory frameworks in the Global ePharmacy Market?

6. What is the market share of the leading vendors in the Global ePharmacy Market?

7. What modes and strategic moves are considered suitable for entering the Global ePharmacy Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. ePharmacy Market, by Product, 2022 vs 2030
  • 4.3. ePharmacy Market, by Drug Type, 2022 vs 2030
  • 4.4. ePharmacy Market, by Type, 2022 vs 2030
  • 4.5. ePharmacy Market, by Business model, 2022 vs 2030
  • 4.6. ePharmacy Market, by Region, 2022 vs 2030

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rapid adoption of digital technologies and eCommerce in healthcare sector for better accessibility and flexibility
      • 5.1.1.2. Evolution of teleconsultation across the globe leads the adoption of ePharmacy facilities
      • 5.1.1.3. Growing geriatric population with chronic and acute conditions across the globe
    • 5.1.2. Restraints
      • 5.1.2.1. Requirement of technical expertise and adequate infrastructure for ePharmacy development
    • 5.1.3. Opportunities
      • 5.1.3.1. Deployment of artificial intelligence and blockchain technology in ePharmacy
      • 5.1.3.2. Introduction of virtual assistance in ePharmacy
    • 5.1.4. Challenges
      • 5.1.4.1. Concern regarding inappropriate labeling of drugs in ePharmacy
      • 5.1.4.2. Issues pertaining to patient's data privacy and security due to emergence of hacking and fishing activities
  • 5.2. Market Trends
  • 5.3. Cumulative Impact of COVID-19
  • 5.4. Cumulative Impact of Russia-Ukraine Conflict
  • 5.5. Cumulative Impact of High Inflation
  • 5.6. Porter's Five Forces Analysis
    • 5.6.1. Threat of New Entrants
    • 5.6.2. Threat of Substitutes
    • 5.6.3. Bargaining Power of Customers
    • 5.6.4. Bargaining Power of Suppliers
    • 5.6.5. Industry Rivalry
  • 5.7. Value Chain & Critical Path Analysis
  • 5.8. Regulatory Framework
  • 5.9. Client Customization

6. ePharmacy Market, by Product

  • 6.1. Introduction
  • 6.2. Cold & Flu
  • 6.3. Dental
  • 6.4. Skin Care
  • 6.5. Vitamins
  • 6.6. Weight Loss

7. ePharmacy Market, by Drug Type

  • 7.1. Introduction
  • 7.2. Over the Counter (OTC) Drugs
  • 7.3. Prescription Drugs

8. ePharmacy Market, by Type

  • 8.1. Introduction
  • 8.2. Integrated
  • 8.3. Standalone

9. ePharmacy Market, by Business model

  • 9.1. Introduction
  • 9.2. Direct
  • 9.3. Marketplace
  • 9.4. Pharmacy

10. Americas ePharmacy Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific ePharmacy Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa ePharmacy Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. FPNV Positioning Matrix
  • 13.2. Market Share Analysis, By Key Player
  • 13.3. Competitive Scenario Analysis, By Key Player
    • 13.3.1. Merger & Acquisition
      • 13.3.1.1. Flipkart In Discussions To Acquire Online Pharmacy Pharmallama
    • 13.3.2. New Product Launch & Enhancement
      • 13.3.2.1. Med-Direct Africa Launches e-Pharmacy, Promises Price Reduction.
      • 13.3.2.2. Flipkart taps healthcare sector with brand new 'Flipkart Health+' app.
    • 13.3.3. Investment & Funding
      • 13.3.3.1. Vietnamese e-pharmacy Medigo raises $2M and more digital health fundings.
      • 13.3.3.2. e-pharmacy Grinta raises US$8 mln to develop its tech platform.
      • 13.3.3.3. Tata 1mg raises $40 mn led by Tata Digital, becomes unicorn.
      • 13.3.3.4. Kenyan e-pharmacy startup MYDAWA banks $1.2m grant funding from Gates.
      • 13.3.3.5. PharmEasy Raises $350 Mn; Becomes India's First Epharmacy Unicorn.
    • 13.3.4. Award, Recognition, & Expansion
      • 13.3.4.1. US startup launches e-pharmacy platform in Myanmar.
      • 13.3.4.2. Med-Direct Africa launches e-Pharmacy in Nigeria.

14. List of Company Mentioned

15. Appendix

  • 15.1. Discussion Guide
  • 15.2. License & Pricing

LIST OF FIGURES

  • FIGURE 1. EPHARMACY MARKET RESEARCH PROCESS
  • FIGURE 2. EPHARMACY MARKET SIZE, 2022 VS 2030
  • FIGURE 3. EPHARMACY MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. EPHARMACY MARKET SIZE, BY PRODUCT, 2022 VS 2030 (%)
  • FIGURE 5. EPHARMACY MARKET SIZE, BY DRUG TYPE, 2022 VS 2030 (%)
  • FIGURE 6. EPHARMACY MARKET SIZE, BY TYPE, 2022 VS 2030 (%)
  • FIGURE 7. EPHARMACY MARKET SIZE, BY BUSINESS MODEL, 2022 VS 2030 (%)
  • FIGURE 8. EPHARMACY MARKET SIZE, BY REGION, 2022 VS 2030 (%)
  • FIGURE 9. EPHARMACY MARKET DYNAMICS
  • FIGURE 10. EPHARMACY MARKET SIZE, BY PRODUCT, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 11. EPHARMACY MARKET SIZE, BY DRUG TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 12. EPHARMACY MARKET SIZE, BY TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 13. EPHARMACY MARKET SIZE, BY BUSINESS MODEL, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS EPHARMACY MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 15. UNITED STATES EPHARMACY MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC EPHARMACY MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA EPHARMACY MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 18. EPHARMACY MARKET, FPNV POSITIONING MATRIX, 2022
  • FIGURE 19. EPHARMACY MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

  • TABLE 1. EPHARMACY MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
  • TABLE 3. EPHARMACY MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. EPHARMACY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 5. EPHARMACY MARKET SIZE, BY COLD & FLU, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 6. EPHARMACY MARKET SIZE, BY DENTAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. EPHARMACY MARKET SIZE, BY SKIN CARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. EPHARMACY MARKET SIZE, BY VITAMINS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. EPHARMACY MARKET SIZE, BY WEIGHT LOSS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. EPHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 11. EPHARMACY MARKET SIZE, BY OVER THE COUNTER (OTC) DRUGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. EPHARMACY MARKET SIZE, BY PRESCRIPTION DRUGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. EPHARMACY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 14. EPHARMACY MARKET SIZE, BY INTEGRATED, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. EPHARMACY MARKET SIZE, BY STANDALONE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. EPHARMACY MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
  • TABLE 17. EPHARMACY MARKET SIZE, BY DIRECT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. EPHARMACY MARKET SIZE, BY MARKETPLACE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. EPHARMACY MARKET SIZE, BY PHARMACY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS EPHARMACY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS EPHARMACY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS EPHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS EPHARMACY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS EPHARMACY MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
  • TABLE 25. ARGENTINA EPHARMACY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 26. ARGENTINA EPHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 27. ARGENTINA EPHARMACY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 28. ARGENTINA EPHARMACY MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
  • TABLE 29. BRAZIL EPHARMACY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 30. BRAZIL EPHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 31. BRAZIL EPHARMACY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 32. BRAZIL EPHARMACY MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
  • TABLE 33. CANADA EPHARMACY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 34. CANADA EPHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. CANADA EPHARMACY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 36. CANADA EPHARMACY MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
  • TABLE 37. MEXICO EPHARMACY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 38. MEXICO EPHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. MEXICO EPHARMACY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 40. MEXICO EPHARMACY MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
  • TABLE 41. UNITED STATES EPHARMACY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 42. UNITED STATES EPHARMACY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 43. UNITED STATES EPHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 44. UNITED STATES EPHARMACY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. UNITED STATES EPHARMACY MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
  • TABLE 46. ASIA-PACIFIC EPHARMACY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 47. ASIA-PACIFIC EPHARMACY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 48. ASIA-PACIFIC EPHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. ASIA-PACIFIC EPHARMACY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. ASIA-PACIFIC EPHARMACY MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
  • TABLE 51. AUSTRALIA EPHARMACY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 52. AUSTRALIA EPHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. AUSTRALIA EPHARMACY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. AUSTRALIA EPHARMACY MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
  • TABLE 55. CHINA EPHARMACY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 56. CHINA EPHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. CHINA EPHARMACY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. CHINA EPHARMACY MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
  • TABLE 59. INDIA EPHARMACY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 60. INDIA EPHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. INDIA EPHARMACY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. INDIA EPHARMACY MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
  • TABLE 63. INDONESIA EPHARMACY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 64. INDONESIA EPHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. INDONESIA EPHARMACY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. INDONESIA EPHARMACY MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
  • TABLE 67. JAPAN EPHARMACY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 68. JAPAN EPHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. JAPAN EPHARMACY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. JAPAN EPHARMACY MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
  • TABLE 71. MALAYSIA EPHARMACY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 72. MALAYSIA EPHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. MALAYSIA EPHARMACY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. MALAYSIA EPHARMACY MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
  • TABLE 75. PHILIPPINES EPHARMACY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 76. PHILIPPINES EPHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. PHILIPPINES EPHARMACY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. PHILIPPINES EPHARMACY MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
  • TABLE 79. SINGAPORE EPHARMACY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 80. SINGAPORE EPHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. SINGAPORE EPHARMACY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. SINGAPORE EPHARMACY MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
  • TABLE 83. SOUTH KOREA EPHARMACY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 84. SOUTH KOREA EPHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. SOUTH KOREA EPHARMACY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. SOUTH KOREA EPHARMACY MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
  • TABLE 87. TAIWAN EPHARMACY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 88. TAIWAN EPHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. TAIWAN EPHARMACY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. TAIWAN EPHARMACY MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
  • TABLE 91. THAILAND EPHARMACY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 92. THAILAND EPHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. THAILAND EPHARMACY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. THAILAND EPHARMACY MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
  • TABLE 95. VIETNAM EPHARMACY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 96. VIETNAM EPHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. VIETNAM EPHARMACY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. VIETNAM EPHARMACY MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
  • TABLE 99. EUROPE, MIDDLE EAST & AFRICA EPHARMACY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 100. EUROPE, MIDDLE EAST & AFRICA EPHARMACY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 101. EUROPE, MIDDLE EAST & AFRICA EPHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 102. EUROPE, MIDDLE EAST & AFRICA EPHARMACY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA EPHARMACY MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
  • TABLE 104. DENMARK EPHARMACY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 105. DENMARK EPHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 106. DENMARK EPHARMACY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 107. DENMARK EPHARMACY MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
  • TABLE 108. EGYPT EPHARMACY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 109. EGYPT EPHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 110. EGYPT EPHARMACY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 111. EGYPT EPHARMACY MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
  • TABLE 112. FINLAND EPHARMACY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 113. FINLAND EPHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 114. FINLAND EPHARMACY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 115. FINLAND EPHARMACY MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
  • TABLE 116. FRANCE EPHARMACY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 117. FRANCE EPHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 118. FRANCE EPHARMACY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 119. FRANCE EPHARMACY MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
  • TABLE 120. GERMANY EPHARMACY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 121. GERMANY EPHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 122. GERMANY EPHARMACY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 123. GERMANY EPHARMACY MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
  • TABLE 124. ISRAEL EPHARMACY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 125. ISRAEL EPHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 126. ISRAEL EPHARMACY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 127. ISRAEL EPHARMACY MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
  • TABLE 128. ITALY EPHARMACY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 129. ITALY EPHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 130. ITALY EPHARMACY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 131. ITALY EPHARMACY MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
  • TABLE 132. NETHERLANDS EPHARMACY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 133. NETHERLANDS EPHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 134. NETHERLANDS EPHARMACY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 135. NETHERLANDS EPHARMACY MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
  • TABLE 136. NIGERIA EPHARMACY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 137. NIGERIA EPHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 138. NIGERIA EPHARMACY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 139. NIGERIA EPHARMACY MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
  • TABLE 140. NORWAY EPHARMACY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 141. NORWAY EPHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 142. NORWAY EPHARMACY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 143. NORWAY EPHARMACY MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
  • TABLE 144. POLAND EPHARMACY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 145. POLAND EPHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 146. POLAND EPHARMACY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 147. POLAND EPHARMACY MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
  • TABLE 148. QATAR EPHARMACY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 149. QATAR EPHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 150. QATAR EPHARMACY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 151. QATAR EPHARMACY MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
  • TABLE 152. RUSSIA EPHARMACY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 153. RUSSIA EPHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 154. RUSSIA EPHARMACY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 155. RUSSIA EPHARMACY MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
  • TABLE 156. SAUDI ARABIA EPHARMACY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 157. SAUDI ARABIA EPHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 158. SAUDI ARABIA EPHARMACY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 159. SAUDI ARABIA EPHARMACY MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
  • TABLE 160. SOUTH AFRICA EPHARMACY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 161. SOUTH AFRICA EPHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 162. SOUTH AFRICA EPHARMACY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 163. SOUTH AFRICA EPHARMACY MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
  • TABLE 164. SPAIN EPHARMACY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 165. SPAIN EPHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 166. SPAIN EPHARMACY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 167. SPAIN EPHARMACY MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
  • TABLE 168. SWEDEN EPHARMACY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 169. SWEDEN EPHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 170. SWEDEN EPHARMACY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 171. SWEDEN EPHARMACY MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
  • TABLE 172. SWITZERLAND EPHARMACY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 173. SWITZERLAND EPHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 174. SWITZERLAND EPHARMACY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 175. SWITZERLAND EPHARMACY MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
  • TABLE 176. TURKEY EPHARMACY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 177. TURKEY EPHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 178. TURKEY EPHARMACY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 179. TURKEY EPHARMACY MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
  • TABLE 180. UNITED ARAB EMIRATES EPHARMACY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 181. UNITED ARAB EMIRATES EPHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 182. UNITED ARAB EMIRATES EPHARMACY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 183. UNITED ARAB EMIRATES EPHARMACY MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
  • TABLE 184. UNITED KINGDOM EPHARMACY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 185. UNITED KINGDOM EPHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 186. UNITED KINGDOM EPHARMACY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 187. UNITED KINGDOM EPHARMACY MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
  • TABLE 188. EPHARMACY MARKET, FPNV POSITIONING MATRIX, 2022
  • TABLE 189. EPHARMACY MARKET SHARE, BY KEY PLAYER, 2022
  • TABLE 190. EPHARMACY MARKET LICENSE & PRICING